Preprint
Review

This version is not peer-reviewed.

Ergothioneine as a Protective Agent Against Age-Related Diseases: Issues Needing More Research

Submitted:

22 April 2026

Posted:

23 April 2026

You are already at the latest version

Abstract
Ergothioneine (ET) is a diet-derived compound that is avidly absorbed and retained by the human body using a specialised transporter, OCTN1. A substantial and growing body of evidence implicates ET in maintaining human health and protecting against age-related diseases, especially neurodegenerative diseases, and multiple studies indicate that low blood ET levels increase the risk of developing age-related diseases. Despite the growing interest in ET, much fundamental work remains to be done on its metabolism, intracellular and intercellular transport (especially in the brain), precise mechanisms of cytoprotection, interactions with the microbiome, mycobiome and human pathogens, and identifying the factors that control body ET levels. This narrative review explores these issues and suggests what research needs to be done to improve our understanding of ET biology.
Keywords: 
;  ;  ;  ;  ;  ;  
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated